Adherex Technologies (NASDAQ:FENC – Get Free Report) and Aurora Cannabis (NASDAQ:ACB – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, earnings and dividends.
Institutional and Insider Ownership
55.5% of Adherex Technologies shares are held by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are held by institutional investors. 10.7% of Adherex Technologies shares are held by insiders. Comparatively, 0.0% of Aurora Cannabis shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Profitability
This table compares Adherex Technologies and Aurora Cannabis’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Adherex Technologies | -6.09% | -5.71% | -2.37% |
| Aurora Cannabis | -32.26% | 4.37% | 3.45% |
Valuation & Earnings
This table compares Adherex Technologies and Aurora Cannabis”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Adherex Technologies | $44.64 million | 7.72 | -$9.74 million | ($0.13) | -75.46 |
| Aurora Cannabis | $247.82 million | 1.39 | -$88.13 million | ($1.41) | -3.72 |
Adherex Technologies has higher earnings, but lower revenue than Aurora Cannabis. Adherex Technologies is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Adherex Technologies has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500.
Analyst Ratings
This is a summary of current recommendations for Adherex Technologies and Aurora Cannabis, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Adherex Technologies | 1 | 1 | 4 | 0 | 2.50 |
| Aurora Cannabis | 2 | 2 | 1 | 0 | 1.80 |
Adherex Technologies currently has a consensus target price of $17.00, suggesting a potential upside of 73.29%. Given Adherex Technologies’ stronger consensus rating and higher probable upside, analysts plainly believe Adherex Technologies is more favorable than Aurora Cannabis.
Summary
Adherex Technologies beats Aurora Cannabis on 10 of the 13 factors compared between the two stocks.
About Adherex Technologies
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina.
About Aurora Cannabis
Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Receive News & Ratings for Adherex Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adherex Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
